Point72 (DIFC)’s Celldex Therapeutics CLDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
2025
Q1
$153K Buy
2024
Q4
Sell
2024
Q3
$480K Buy
2024
Q2
$259K Sell
2024
Q1
$471K Buy